Enzon Pharmaceuticals, Inc. financial data

Symbol
ENZN on OTC
Location
20 Commerce Drive, Suite 135, Cranford, NJ
State of incorporation
DE
Fiscal year end
December 31
Former names
ENZON PHARMACEUTICAL INC (to 12/10/2002), ENZON INC (to 12/9/2002)
Latest financial report
10-K - Q4 2024 - Feb 21, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 6.14K % -3.71%
Return On Equity 25.7 % -44.7%
Return On Assets 1.65 % -43.4%
Operating Margin -4K % -10.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 74.2M shares
Common Stock, Shares, Outstanding 74.2M shares 0%
Entity Public Float 6.81M USD -10.2%
Common Stock, Value, Issued 742K USD 0%
Weighted Average Number of Shares Outstanding, Basic 74.2M shares 0%
Weighted Average Number of Shares Outstanding, Diluted 74.2M shares 0%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 26K USD
Operating Income (Loss) -1.33M USD -27.1%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 1.13M USD -7.56%
Income Tax Expense (Benefit) 347K USD
Net Income (Loss) Attributable to Parent 778K USD -43.3%
Earnings Per Share, Basic -0.01 USD/shares
Earnings Per Share, Diluted -0.01 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 46.9M USD -0.33%
Other Assets, Current 293K USD -11.5%
Assets, Current 47.2M USD -0.4%
Deferred Income Tax Assets, Net 17K USD -95.3%
Assets 47.2M USD -1.12%
Accounts Payable, Current 331K USD 0%
Accrued Liabilities, Current 72K USD -33.3%
Liabilities, Current 1.68M USD -2.1%
Retained Earnings (Accumulated Deficit) -69.9M USD +1.1%
Stockholders' Equity Attributable to Parent 3.01M USD -14.2%
Liabilities and Equity 47.2M USD -1.12%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 251K USD +47.6%
Net Cash Provided by (Used in) Financing Activities -1.28M USD 0%
Common Stock, Shares Authorized 170M shares 0%
Common Stock, Shares, Issued 74.2M shares 0%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.02M USD +7.33%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 46.9M USD -0.33%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD
Deferred Tax Assets, Valuation Allowance 32.4M USD -4.89%
Deferred Tax Assets, Gross 32.4M USD -5.84%
Deferred Income Tax Expense (Benefit) 342K USD
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 2.96M shares 0%
Preferred Stock, Shares Outstanding 0 shares
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%